Joshua Zeidner Co-Authored a Study on a Promising Novel Drug for Acute Myeloid Leukemia
June 18, 2025
Joshua Zeidner, MD, associate professor of medicine and chief of leukemia research at UNC Lineberger, is the corresponding author of a newly published study on a promising treatment approach for acute myeloid leukemia (AML). The early-phase clinical trial, conducted at 12 centers nationwide, tested whether adding the oral menin inhibitor...